0.40Open0.70Pre Close10 Volume10 Open Interest7.50Strike Price380.00Turnover55.72%IV4.18%PremiumDec 20, 2024Expiry Date0.09Intrinsic Value100Multiplier17DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type-0.5096Delta0.4445Gamma18.53Leverage Ratio-0.0100Theta-0.0018Rho-9.44Eff Leverage0.0064Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet